诱导、桥接还是直接进行：晚期骨髓增生异常综合征同种异体移植中持续存在的困境 - Suppr

Suppr

超能文献

Induction, Bridging, or Straight Ahead: The Ongoing Dilemma of Allografting in Advanced Myelodysplastic Syndrome.

作者信息

Kröger Nicolaus

机构信息

Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Biol Blood Marrow Transplant. 2019 Aug;25(8):e247-e249. doi: 10.1016/j.bbmt.2019.06.016. Epub 2019 Jun 20.

DOI:10.1016/j.bbmt.2019.06.016

PMID:31229640

Abstract

摘要

相似文献

Induction, Bridging, or Straight Ahead: The Ongoing Dilemma of Allografting in Advanced Myelodysplastic Syndrome.诱导、桥接还是直接进行：晚期骨髓增生异常综合征同种异体移植中持续存在的困境

Biol Blood Marrow Transplant. 2019 Aug;25(8):e247-e249. doi: 10.1016/j.bbmt.2019.06.016. Epub 2019 Jun 20.

Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant.化疗与去甲基化药物治疗异基因造血干细胞移植后复发的急性髓系白血病和骨髓增生异常综合征的对比

Biol Blood Marrow Transplant. 2016 Jul;22(7):1324-1329. doi: 10.1016/j.bbmt.2016.03.023. Epub 2016 Mar 26.

Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia.同种异体造血干细胞移植治疗儿童治疗相关骨髓增生异常综合征或急性髓系白血病。

Biol Blood Marrow Transplant. 2012 Mar;18(3):473-80. doi: 10.1016/j.bbmt.2011.11.009. Epub 2011 Nov 10.

Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome.在高危、复发或难治性急性髓系白血病和高级别骨髓增生异常综合征患者中，使用克拉屈滨/阿糖胞苷联合减低强度预处理和异基因造血干细胞移植进行细胞减灭治疗。

Eur J Haematol. 2012 Jan;88(1):52-60. doi: 10.1111/j.1600-0609.2011.01703.x. Epub 2011 Nov 17.

Should patients with high-risk or transformed myelodysplastic syndrome proceed directly to allogeneic transplant without prior cytoreduction by remission-induction chemotherapy or hypomethylating agent therapy?高危或转化型骨髓增生异常综合征患者是否应在未接受缓解诱导化疗或去甲基化药物治疗进行预先细胞减灭的情况下直接进行异基因移植？

Clin Lymphoma Myeloma Leuk. 2014 Sep;14 Suppl:S42-5. doi: 10.1016/j.clml.2014.06.015.

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.噻替派、白消安和环磷酰胺作为晚期骨髓增生异常综合征和急性髓性白血病同种异体移植的预处理方案。

Am J Hematol. 2001 Aug;67(4):227-33. doi: 10.1002/ajh.1121.

[Mini-transplant for acute myeloblastic leukemia and myelodysplastic syndrome].[急性髓细胞白血病和骨髓增生异常综合征的微型移植]

Nihon Rinsho. 2003 Sep;61(9):1565-72.

Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis.50岁以上患者异基因造血干细胞移植治疗骨髓增生异常综合征和急性髓系白血病的减低强度预处理：一项系统评价和荟萃分析

J Cancer Res Clin Oncol. 2017 Sep;143(9):1853-1864. doi: 10.1007/s00432-017-2429-z. Epub 2017 May 3.

Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.异基因造血移植后的混合性T淋巴细胞嵌合现象可预测急性髓系白血病和骨髓增生异常综合征的复发。

Biol Blood Marrow Transplant. 2015 Nov;21(11):1948-54. doi: 10.1016/j.bbmt.2015.07.005. Epub 2015 Jul 14.

Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.针对患有5号和/或7号染色体异常的急性髓系白血病或骨髓增生异常综合征患者进行异基因干细胞移植。

Haematologica. 2005 Oct;90(10):1339-45.

引用本文的文献

Allogeneic Stem Cell Transplant for Myelofibrosis and Myelodysplastic Syndromes: A Contemporary Review.异基因干细胞移植治疗骨髓纤维化和骨髓增生异常综合征：当代综述

Am J Hematol. 2025 Jun;100 Suppl 4(Suppl 4):16-29. doi: 10.1002/ajh.27660. Epub 2025 Mar 13.

Treatment of high-risk myelodysplastic syndromes.高危骨髓增生异常综合征的治疗

Haematologica. 2025 Feb 1;110(2):339-349. doi: 10.3324/haematol.2023.284946.

Iron chelation improves ineffective erythropoiesis and iron overload in myelodysplastic syndrome mice.铁螯合作用可改善骨髓增生异常综合征小鼠无效造血和铁过载。

Elife. 2023 Dec 28;12:e83103. doi: 10.7554/eLife.83103.

Normal and dysregulated crosstalk between iron metabolism and erythropoiesis.正常和失调的铁代谢与红细胞生成之间的相互作用。

Elife. 2023 Aug 14;12:e90189. doi: 10.7554/eLife.90189.

Myelodysplastic Syndromes: New Methods of Diagnosis, Prognostication, and Treatment.骨髓增生异常综合征：新的诊断、预后和治疗方法。

Dtsch Arztebl Int. 2023 Mar 24;120(12):203-210. doi: 10.3238/arztebl.m2023.0005.

Prognostic impact of Auer rods for cytoreductive chemotherapy and myeloablative allogeneic stem cell transplantation in adult patients with myelodysplastic syndrome with excess blasts-2.奥厄小体对伴有过多原始细胞-2的骨髓增生异常综合征成年患者进行细胞减灭性化疗和清髓性异基因干细胞移植的预后影响

Ann Hematol. 2022 Jul;101(7):1611-1615. doi: 10.1007/s00277-022-04808-9. Epub 2022 Mar 2.

Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study.随着时间的推移，异基因造血细胞移植治疗血液系统恶性肿瘤后移植物抗宿主病患者的结局得到改善：一项 EBMT 大文件研究。

Haematologica. 2022 May 1;107(5):1054-1063. doi: 10.3324/haematol.2020.265769.

Myelodysplastic syndromes: moving towards personalized management.骨髓增生异常综合征：走向个体化治疗。

Haematologica. 2020 Jul;105(7):1765-1779. doi: 10.3324/haematol.2020.248955. Epub 2020 May 21.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验